Trial intelligence / Profile preview

YH14618 single intradiscal injection in degenerative disc disease

KCT0001037Phase 2Completed

Sponsor
Yuhan
Start
Aug 2012
Modality
Peptides
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in degenerative disc disease (DDD) comparing YH14618 intradiscal injection with Placebo intradiscal injection (2 arms). Started Aug 2012; status: completed.

02

Drugs

vicatertide
03

Conditions

degenerative disc disease (DDD)

Beyond the preview

Go deeper on KCT0001037.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0001037.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call